ZMC-003

N/A

Report date: 2025/11/06 17:16:11
NME

Base Information

Drug NameZMC-003
Drug Alias NameZMC-003
ClassificationSmall molecules
Mechanisms of ActionLysine-tRNA ligase inhibitors
TargetsLysine-tRNA ligase
Therapy Area/IndicationsNephrosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZymedi Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZymedi Co Ltd
Inactive CompaniesN/A
Active IndicationsNephrosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A